An interpretable machine learning model for predicting distant organ metastasis after radical resection of colorectal cancer

一种用于预测结直肠癌根治术后远处器官转移的可解释机器学习模型

阅读:2

Abstract

OBJECTIVE: Distant organ metastasis remains the primary factor affecting long-term survival following radical surgery for colorectal cancer (CRC). This study aimed to develop and validate an interpretable machine learning (ML) model to predict the 5-year cumulative risk of distant metastasis after radical CRC surgery. METHODS: A retrospective observational cohort study was conducted using clinical and follow-up data from 341 CRC patients who underwent radical surgery. The cohort was randomly divided into a training set n=239 and a validation set n=102 at a 7:3 ratio. Feature selection was performed using least absolute shrinkage and selection operator (LASSO) regression, identifying variables associated with the 5-year cumulative occurrence of metastasis. Prediction models were constructed using seven algorithms. Model performance was evaluated through multiple metrics: area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, F1 score, calibration plots, and decision curve analysis. The SHapley Additive exPlanations (SHAP) method was applied to improve model interpretability. RESULTS: LASSO combined with tenfold cross-validation selected 11 key features for model development. Among the models tested, the SVM model demonstrated superior performance, achieving a Brier score of 0.144 and an AUC of 0.865 in the validation set. Calibration and clinical decision curves confirmed the SVM model's strong calibration and clinical applicability. The SHAP dependence plots and force analysis provided explanations at both feature and individual patient levels for the model's 5-year risk predictions. CONCLUSION: This study established a high-accuracy and interpretable ML model capable of effectively predicting the 5-year cumulative risk of distant organ metastasis after radical colorectal cancer surgery, while further external validation is necessary to confirm its clinical utility.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。